MA (EU) number
(Invented) 
name
Strength Pharmaceutical form Route of 
administration
Immediate 
Packaging
Content 
(concentration)
Pack size
EU/1/23/1752/001
Abrysvo
--¹
Powder and solvent for 
solution for injection
Intramuscular 
use
powder: vial (glass); 
solvent: pre-filled 
syringe (glass)
0.5 ml
EU/1/23/1752/002
Abrysvo
--¹
Powder and solvent for 
solution for injection
Intramuscular 
use
EU/1/23/1752/003
Abrysvo
--¹
Powder and solvent for 
solution for injection
Intramuscular 
use
EU/1/23/1752/004
Abrysvo
--¹
Powder and solvent for 
solution for injection
Intramuscular 
use
EU/1/23/1752/005
Abrysvo
--¹
Powder and solvent for 
solution for injection
Intramuscular 
use
powder: vial (glass); 
solvent: pre-filled 
syringe (glass)
0.5 ml
powder: vial (glass); 
solvent: pre-filled 
syringe (glass)
0.5 ml
powder: vial (glass); 
solvent: pre-filled 
syringe (glass)
0.5 ml
powder: vial (glass); 
solvent: pre-filled 
syringe (glass)
0.5 ml
EU/1/23/1752/006
Abrysvo
--¹
Powder and solvent for 
solution for injection
Intramuscular 
use
powder: vial (glass); 
solvent: pre-filled 
syringe (glass)
0.5 ml
--¹
After reconstitution, one dose (0.5 mL) contains:
RSV subgroup A stabilised prefusion F antigen*,** 60 micrograms
RSV subgroup B stabilised prefusion F antigen*,** 60 micrograms
* glycoprotein F stabilised in the prefusion conformation
** produced in Chinese Hamster Ovary cells by recombinant DNA technology
1 vial + 1 vial 
adaptor + 1 
pre-filled 
syringe + 1 
needle 
1 vial + 1 vial 
adaptor + 1 
pre-filled 
syringe 
5 vials + 5 
vial adaptors 
+ 5 pre-filled 
syringes + 5 
needles 
5 vials + 5 
vial adaptors 
+ 5 pre-filled 
syringes 
10 vials + 10 
vial adaptors 
+ 10 pre-filled 
syringes + 10 
needles 
10 vials + 10 
vial adaptors 
+ 10 pre-filled 
syringes 
1/1
